Pages that link to "Q53839704"

The following pages link to Expression of somatostatin receptor subtypes 2 and 4 in human benign prostatic hyperplasia and prostatic cancer. (Q53839704):

Displaying 22 items.

• Neuroendocrine differentiation in prostate cancer (Q24657547) (← links)
• Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapse (Q28540624) (← links)
• Near infrared photonic finger imager for prostate cancer screening (Q34069799) (← links)
• Somatostatin receptors and their interest in diagnostic pathology (Q36024996) (← links)
• Somatostatin, somatostatin receptors, and pancreatic cancer (Q36038482) (← links)
• Additional information gained by positron emission tomography with (68)Ga-DOTATOC for suspected unknown primary or recurrent neuroendocrine tumors (Q36322884) (← links)
• Neuroendocrine differentiation in the progression of prostate cancer (Q37361501) (← links)
• Somatostatin Receptors in Non-Neuroendocrine Malignancies: The Potential Role of Somatostatin Analogs in Solid Tumors (Q37898112) (← links)
• Neuroendocrine differentiation of prostate cancer: a review (Q38326554) (← links)
• miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis (Q38875539) (← links)
• miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients (Q39168818) (← links)
• Effective treatment of experimental androgen sensitive and androgen independent intraosseous prostate cancer with targeted cytotoxic somatostatin analogue AN-238. (Q40600946) (← links)
• Somatostatin receptors over-expression in castration resistant prostate cancer detected by PET/CT: preliminary report of in six patients (Q41558340) (← links)
• Somatostatin receptor subtypes in hormone-refractory (castration-resistant) prostatic carcinoma (Q41828518) (← links)
• Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation (Q42474654) (← links)
• Somatostatin analogs for the treatment of advanced, hormone-refractory prostate cancer: a possibility for secondary hormonal ablation? (Q44808680) (← links)
• Visualization of somatostatin receptors in prostate cancer and its bone metastases with Ga-68-DOTATOC PET/CT. (Q46022237) (← links)
• Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer. (Q46757943) (← links)
• Italian Society of Endocrinology Career Award Lecture: from somatostatin to…somatomedin. (Q48289552) (← links)
• Expression of somatostatin and its receptor 1-5 in endometriotic tissues and cells (Q58552314) (← links)
• Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer (Q84010096) (← links)
• Evaluation of Somatostatin and CXCR4 Receptor Expression in a Large Set of Prostate Cancer Samples Using Tissue Microarrays and Well-Characterized Monoclonal Antibodies (Q95924579) (← links)